Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL was delisted on the 29th of September, 2022.
11 hedge funds and large institutions have $47.6M invested in Zealand Pharma A/S American Depositary Shares in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
44% more capital invested
Capital invested by funds: $33M → $47.6M (+$14.5M)
15% less funds holding
Funds holding: 13 → 11 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$730K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$18K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$788K |
| 2 |
Jane Street
New York
|
-$320K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$203K |
| 4 |
Morgan Stanley
New York
|
-$16.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.71K |
ZEAL Hedge Fund Activity: Q1 2019 in Review
11 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Zealand Pharma A/S American Depositary Shares (ZEAL) for Q1 2019, worth a combined $47.6M — up 44% from $33M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ZEAL and 1 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 1 added.
The largest buyer was Farallon Capital Management, adding an estimated $730K. The largest seller was Wellington Management Group, cutting an estimated $788K.
- 11 institutional investors held Zealand Pharma A/S American Depositary Shares (ZEAL) as of Q1 2019, down from 13 in Q4 2018.
- Funds reported $47.6M of Zealand Pharma A/S American Depositary Shares stock for Q1 2019, up 44% quarter-over-quarter.
- 1 fund opened new Zealand Pharma A/S American Depositary Shares positions in Q1 2019 and 3 closed out, a net change of -2 holders.
- The largest Zealand Pharma A/S American Depositary Shares buyer in Q1 2019 was Farallon Capital Management, an estimated $730K added.
- The largest Zealand Pharma A/S American Depositary Shares seller in Q1 2019 was Wellington Management Group, an estimated $788K sold.
Based on aggregated 13F filings for Q1 2019.